Evaluation Of Stress Response In Diabetic Hypertensive Patients

December 20, 2022 updated by: Iliriana Alloqi Tahirbegolli, Istanbul University

Diyabetik Hipertansif Hastalarda Stres Yanıtının Değerlendirilmesi

In this research, we aimed to examine salivary cortisol changes in the cognitive stress response of patients with Hypertension + Diabetes Mellitus (HT+DM) and Hypertension (HT) and to determine the differences between them.

The research was conducted by solving an arithmetic task as a stress test in 62 patients with HT+DM and HT that are being treated in the outpatient clinic of Medical Pharmacology and Clinical Pharmacology Department at Istanbul University, Istanbul Medical Faculty Hospital.

Study Overview

Detailed Description

In this study, saliva samples were taken for cortisol measurement, and patients were instructed to place the cotton piece in the salivette® tubes directly into their mouths without touching it with anything, hold it for 30-60 seconds, and then insert it back into the tubes in the same way, four times total, once before arithmetic stress and three times after stress, on Tuesdays, Wednesdays, and Thursdays between the hours of 12:00-16:00.

Salivary cortisol was measured using the electro-chemiluminescence immunoassay.

Study Type

Observational

Enrollment (Actual)

62

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey, 34000
        • Istanbul University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

36 years to 61 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Sampling Method

Non-Probability Sample

Study Population

The study population consisted of patients in the register of the pharmacology clinic of the faculty of medicine who have a diagnosis of hypertension and diabetes mellitus type 2.

Description

Inclusion Criteria:

  1. Using antihypertensive treatment for the last 3 months
  2. Diagnosed with Type 2 Diabetes Mellitus and taking medication for at least 3 months
  3. Being between the ages of 40-65
  4. Being male
  5. Having signed the informed consent form

Exclusion Criteria:

  1. Female gender
  2. Patients younger than 40 years old or older than 65 years old
  3. Uncontrolled blood pressure (SBP>140 mmHg, DBP>90 mmHg)
  4. Using antipsychotic medication
  5. Using current treatment for less than 3 months
  6. Having a previous MI
  7. Having a previous stroke
  8. Having a lung disease
  9. Having organ failure
  10. Having Cushing's disease
  11. Having aldosteronism
  12. Failure to sign the informed consent form

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Hypertension + Diabetes Mellitus (HT+DM)

Patients who fulfilled the following criteria were included in this group:

  1. Using antihypertensive treatment for the last 3 months
  2. Diagnosed with Type 2 Diabetes Mellitus and taking medication for at least 3 months
  3. Being between the ages of 40-65
  4. Being male
  5. Having signed the informed consent form

In a quiet environment, a white paper in A4 format was placed in front of the patient on the table, and the patients were asked to subtract the number 3 from 2907 for 100 seconds.

The researcher was standing in front of the patient and asks to make corrections by giving a warning whenever the patient made a mistake in the calculation.

In the same A4-sized white paper that was placed in front of each patient on a table, immediately after the first subtraction process, patients were asked to subtract 7 from 6828 for another 100 seconds.

When the patient made a calculating error, the researcher stood in front of the patient and asked them to make corrections by issuing a warning.

In the same A4-sized white paper that was placed in front of each patient on a table, immediately after the previous subtraction process, patients were asked to subtract 13 from 9561 for another 100 seconds.

When the patient made a calculating error, the researcher stood in front of the patient and asked them to make corrections by issuing a warning.

In the same A4-sized white paper that was placed in front of each patient on a table, immediately after the previous subtraction process, patients were asked to subtract 8 from 5113 for another 100 seconds.

When the patient made a calculating error, the researcher stood in front of the patient and asked them to make corrections by issuing a warning.

In the same A4-sized white paper that was placed in front of each patient on a table, immediately after the previous subtraction process, patients were asked to subtract 14 from 8318 for another 100 seconds.

When the patient made a calculating error, the researcher stood in front of the patient and asked them to make corrections by issuing a warning.

In the same A4-sized white paper that was placed in front of each patient on a table, immediately after the previous subtraction process, patients were asked to subtract 17 from 9994 for another 100 seconds.

When the patient made a calculating error, the researcher stood in front of the patient and asked them to make corrections by issuing a warning.

Hypertension (HT)

Patients who fulfilled the following criteria were included in this group:

  1. Using antihypertensive treatment for the last 3 months
  2. Being between the ages of 40-65
  3. Being male
  4. Having signed the informed consent form

In a quiet environment, a white paper in A4 format was placed in front of the patient on the table, and the patients were asked to subtract the number 3 from 2907 for 100 seconds.

The researcher was standing in front of the patient and asks to make corrections by giving a warning whenever the patient made a mistake in the calculation.

In the same A4-sized white paper that was placed in front of each patient on a table, immediately after the first subtraction process, patients were asked to subtract 7 from 6828 for another 100 seconds.

When the patient made a calculating error, the researcher stood in front of the patient and asked them to make corrections by issuing a warning.

In the same A4-sized white paper that was placed in front of each patient on a table, immediately after the previous subtraction process, patients were asked to subtract 13 from 9561 for another 100 seconds.

When the patient made a calculating error, the researcher stood in front of the patient and asked them to make corrections by issuing a warning.

In the same A4-sized white paper that was placed in front of each patient on a table, immediately after the previous subtraction process, patients were asked to subtract 8 from 5113 for another 100 seconds.

When the patient made a calculating error, the researcher stood in front of the patient and asked them to make corrections by issuing a warning.

In the same A4-sized white paper that was placed in front of each patient on a table, immediately after the previous subtraction process, patients were asked to subtract 14 from 8318 for another 100 seconds.

When the patient made a calculating error, the researcher stood in front of the patient and asked them to make corrections by issuing a warning.

In the same A4-sized white paper that was placed in front of each patient on a table, immediately after the previous subtraction process, patients were asked to subtract 17 from 9994 for another 100 seconds.

When the patient made a calculating error, the researcher stood in front of the patient and asked them to make corrections by issuing a warning.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cortisol
Time Frame: Baseline
A saliva sample is collected for cortisol evaluation
Baseline
Cortisol
Time Frame: 30 minutes after beginning
A saliva sample is collected
30 minutes after beginning
Cortisol
Time Frame: 45 minutes after beginning
A saliva sample is collected
45 minutes after beginning
Cortisol
Time Frame: 60 minutes after beginning
A saliva sample is collected
60 minutes after beginning
Blood pressure
Time Frame: Baseline
The patient is rested by sitting before the measurement
Baseline
Blood pressure
Time Frame: 15 minutes after beginning measurement
The patient is rested by sitting before the measurement
15 minutes after beginning measurement
Blood pressure
Time Frame: 35 minutes after beginning measurement
The patient is rested by sitting before the measurement
35 minutes after beginning measurement
Blood pressure
Time Frame: 50 minutes after beginning measurement
The patient is rested by sitting before the measurement
50 minutes after beginning measurement
Blood pressure
Time Frame: 75 minutes after beginning measurement
The patient is rested by sitting before the measurement
75 minutes after beginning measurement
Aldosterone
Time Frame: Baseline
Venous blood sample is collected
Baseline
Heart Rate
Time Frame: Beginning
The patient is rested by sitting before the measurement
Beginning
Heart Rate
Time Frame: 15 minutes after beginning
The patient is rested by sitting before the measurement
15 minutes after beginning
Heart Rate
Time Frame: 35 minutes after beginning
The patient is rested by sitting before the measurement
35 minutes after beginning
Heart Rate
Time Frame: 50 minutes after beginning
The patient is rested by sitting before the measurement
50 minutes after beginning
Heart Rate
Time Frame: 75 minutes after beginning
The patient is rested by sitting before the measurement
75 minutes after beginning

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mental state examination
Time Frame: Baseline
Mini Mental State Examination - MMSE is used to evaluate the mental state
Baseline
Physical activity
Time Frame: Baseline
International Physical Activity Questionnaire is used to evaluate the level of physical activity
Baseline
Health related Quality of life
Time Frame: Baseline
SF-36 v2 is used to evaluate the health related quality of life
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Iliriana Alloqi Tahirbegolli, Prof.Ass.Dr., Istanbul University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2016

Primary Completion (Actual)

November 30, 2017

Study Completion (Actual)

September 4, 2018

Study Registration Dates

First Submitted

August 1, 2022

First Submitted That Met QC Criteria

December 20, 2022

First Posted (Actual)

December 23, 2022

Study Record Updates

Last Update Posted (Actual)

December 23, 2022

Last Update Submitted That Met QC Criteria

December 20, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 22939

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

Based on the regulations it is not mandatory for this study to share the individual data of patients. But in the case of a proper request by researchers the data can be shared by the principal researcher of the study.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on First arithmetic problem solving

Subscribe